Featured Research

from universities, journals, and other organizations

Infection with tickborne parasite may suppress malaria

Date:
March 24, 2010
Source:
American Society for Microbiology
Summary:
A new study suggests that monkeys chronically infected with babesiosis, a tick-borne parasite, are able to suppress malaria infection when exposed to a simian malaria parasite.

A new study suggests that monkeys chronically infected with babesiosis, a tick-borne parasite, are able to suppress malaria infection when exposed to a simian malaria parasite.

The researchers from the Biomedical Primate Research Center, Rijswijk, The Netherlands report their findings in the March 2010 issue of the journal Infection and Immunity.

Babesia parasites are known to infect a wide variety of mammalian hosts and awareness of the role these organisms play as zoonotic agents of human disease is growing. Of the population infected with Babesia microti, 25% of adults and 50% of children remain asymptomatic. Human malaria is caused by four different Plasmodium species, however, Plasmodium falciparum and Plasmodium vivax are the most significant with P. falciparum attributed to more than 1 million deaths annually in sub-Saharan Africa.

Prior studies of Babesia and Plasmodium coinfection in rodents have reported induced cross-protection. In an attempt to confirm their prior report that a rhesus macaque chronically infected with B. microti was able to suppress infection with Plasmodium cynomolgi (a parasite of macaques with attributes similar to P. vivax), researchers infected six naive monkeys with B. microti and then 24 days later challenged four of them plus four naοve monkeys with P. cynomolgi blood-stage parasites. Results showed a significant decrease in P. cynomolgi infection in monkeys coinfected with B. microti.

"We conclude that ongoing infection with B. microti parasites leads to suppression of malaria infection," say the researchers.


Story Source:

The above story is based on materials provided by American Society for Microbiology. Note: Materials may be edited for content and length.


Journal Reference:

  1. L. M. van Duivenvoorde, A. Voorberg-van der Wel, N. M. van der Werff, G. Braskamp, E. J. Remarque, I. Kondova, C. H. M. Kocken, A. W. Thomas. Suppression of Plasmodium cynomolgi in Rhesus Macaques by Coinfection with Babesia microti. Infection and Immunity, 2010; 78 (3): 1032 DOI: 10.1128/IAI.00921-09

Cite This Page:

American Society for Microbiology. "Infection with tickborne parasite may suppress malaria." ScienceDaily. ScienceDaily, 24 March 2010. <www.sciencedaily.com/releases/2010/03/100323224028.htm>.
American Society for Microbiology. (2010, March 24). Infection with tickborne parasite may suppress malaria. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2010/03/100323224028.htm
American Society for Microbiology. "Infection with tickborne parasite may suppress malaria." ScienceDaily. www.sciencedaily.com/releases/2010/03/100323224028.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins